The Valley Desk

NCT07601295 · Interventional trial

Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)

Overall registry status Enrolling by invitation

Phase 2

Conditions Pulmonary Arterial Hypertension (PAH)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov